Form 4: Director John G. Danhakl Acquires IQVIA Shares

IQVIA Holdings Inc. director John G. Danhakl acquired 1,571 shares of common stock as part of a non-employee director equity award.

Summary

• Director John G. Danhakl received an award of 1,571 shares of IQVIA Holdings Inc. common stock.
• The shares were granted as part of the standard compensation for non-employee directors.
• The shares are fully vested upon the grant date of April 23, 2026.
• Following this transaction, the reporting person beneficially owns 30,612 shares through a trust and 1,275 shares through an LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director alignment with shareholder interests through increased equity ownership.
• The grant represents fully vested compensation, indicating no performance-based clawback risk.

Negatives

• None identified; this is a routine compensatory equity grant.

Risks

• None identified; this is a standard regulatory disclosure of director compensation.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine equity grants to non-employee directors are standard practice in the healthcare technology and clinical research sector to ensure board alignment with long-term corporate performance.

Comparison to Industry Standards

• The grant structure is consistent with standard corporate governance practices for S&P 500 companies.
• Equity-based compensation for directors is a common industry benchmark to incentivize oversight and strategic guidance.

Related Party Transactions

• Shares held in the Danhakl Revocable Family Trust and an LLC controlled by the trust.

Stakeholder Impact

• Minimal impact; reflects standard director compensation practices.

Next Steps

• None

Key Dates

Keywords

IQVIA, Insider Trading, Director Compensation, Equity Grant, Form 4